PARTNERSHIPS & INVESTORS
Collaborations That Give Patients Help and Hope
Our mission to provide transformative therapies is possible only through the partnerships we form and the investments we receive. In 2020 we closed a CHF54M Series A financing round, led by Sofinnova Partners and Polaris Partners, following a seed investment from Sofinnova Partners. In 2023 we closed a CHF103M Series B financing round, led by Forbion and Jeito Capital.